Breaking News Instant updates and real-time market news.

AME

Ametek

$85.84 /

+0.19 (+0.22%)

, ITT

ITT

$62.31 /

+0.445 (+0.72%)

08:15
04/17/19
04/17
08:15
04/17/19
08:15

Ametek, ITT among top potential acquirers in industrial space, says KeyBanc

KeyBanc analysts Jeff Hammond and Steve Barger think moderating organic growth expectations in 2019 due to tough year over year comps may drive industrials to increasingly look toward inorganic avenues for market outgrowth, or to potentially divest businesses to right-size portfolios. The analysts view Ametek (AME), ITT (ITT), Graco (GGG), and Timken (TKR) as the top potential acquirers, and think Actuant (ATU), Colfax (CFX), Eaton (ETN), Kaman (KAMN), NN, Inc. (NNBR), and Milacron (MCRN) could benefit most from a strategic divestiture.

AME

Ametek

$85.84 /

+0.19 (+0.22%)

ITT

ITT

$62.31 /

+0.445 (+0.72%)

GGG

Graco

$52.77 /

+0.04 (+0.08%)

TKR

Timken

$48.00 /

+0.55 (+1.16%)

ATU

Actuant

$25.62 /

+0.06 (+0.23%)

CFX

Colfax

$30.66 /

+0.23 (+0.76%)

ETN

Eaton

$84.19 /

+0.53 (+0.63%)

KAMN

Kaman

$60.67 /

+0.03 (+0.05%)

NNBR

NN, Inc.

$9.84 /

+0.01 (+0.10%)

MCRN

Milacron

$14.27 /

+0.4 (+2.88%)

  • 17

    Apr

  • 23

    Apr

  • 25

    Apr

  • 26

    Apr

  • 30

    Apr

  • 30

    Apr

  • 01

    May

  • 01

    May

  • 02

    May

  • 07

    May

  • 13

    May

  • 13

    May

  • 14

    May

  • 15

    May

  • 16

    May

  • 16

    May

  • 15

    Aug

  • 16

    Aug

  • 13

    Nov

AME Ametek
$85.84 /

+0.19 (+0.22%)

03/15/19 DA Davidson
Ametek price target raised to $92 from $87 at DA Davidson
01/08/19 Wolfe Research
Ametek upgraded to Outperform from Peer Perform at Wolfe Research
01/02/19 Stephens
CBS, Global Payments, Union Pacific among Stephens' best ideas for 2019
12/18/18
Fly Intel: Top five analyst upgrades
ITT ITT
$62.31 /

+0.445 (+0.72%)

02/28/19 UBS
ITT upgraded to Neutral from Sell at UBS
10/12/18 Gordon Haskett
ITT initiated with a Buy at Gordon Haskett
08/06/18 DA Davidson
ITT price target raised to $70 from $60 at DA Davidson
08/06/18 Oppenheimer
ITT price target raised to $67 from $60 at Oppenheimer
GGG Graco
$52.77 /

+0.04 (+0.08%)

01/25/19 Jefferies
Graco initiated with a Hold at Jefferies
08/20/18 DA Davidson
Graco investor meetings suggest greater management confidence, says DA Davidson
TKR Timken
$48.00 /

+0.55 (+1.16%)

12/03/18 BofA
Timken upgraded to Buy from Neutral at BofA/Merrill
10/02/18 Goldman Sachs
Timken initiated with a Neutral at Goldman Sachs
08/08/18
Timken upgraded to Neutral at BofA/Merrill
08/08/18 BofA
Timken upgraded to Neutral from Underperform at BofA/Merrill
ATU Actuant
$25.62 /

+0.06 (+0.23%)

01/28/19 JPMorgan
Actuant upgraded to Neutral from Underweight at JPMorgan
12/24/18 BMO Capital
Actuant price target lowered to $22 from $25 at BMO Capital
12/21/18 Baird
Actuant selloff unjustified, but understandable, says Baird
06/21/18 RBC Capital
Actuant price target raised to $28 from $24 at RBC Capital
CFX Colfax
$30.66 /

+0.23 (+0.76%)

04/05/19 Goldman Sachs
Colfax reinstated with a Buy from Neutral at Goldman Sachs
03/15/19
Fly Intel: Top five analyst upgrades
03/15/19 Barclays
Barclays upgrades Colfax to Equal Weight on 'undemanding' valuation
03/15/19 Barclays
Colfax upgraded to Equal Weight from Underweight at Barclays
ETN Eaton
$84.19 /

+0.53 (+0.63%)

04/04/19 BofA
Eaton downgraded to Neutral on valuation at BofA/Merrill
04/02/19 JPMorgan
March Class 8 truck orders drop 66% year-over-year, says JPMorgan
04/02/19 JMP Securities
Hubbell spin off of lighting business would be good idea, says JMP Securities
03/12/19
Fly Intel: Top five analyst upgrades
KAMN Kaman
$60.67 /

+0.03 (+0.05%)

12/14/18
On The Fly: Top five analyst downgrades
12/14/18 JPMorgan
Kaman downgraded to Underweight from Neutral at JPMorgan
07/12/18 JPMorgan
Kaman initiated with a Neutral at JPMorgan
NNBR NN, Inc.
$9.84 /

+0.01 (+0.10%)

03/18/19 Truist
NN price target lowered to $16 from $18 at SunTrust
03/15/19 Baird
NN, Inc. price target lowered to $9 from $11 at Baird
01/07/19 JPMorgan
NN, Inc. initiated with an Overweight at JPMorgan
11/09/18 Lake Street
NN, Inc. selloff yesterday brings attractive entry point, says Lake Street
MCRN Milacron
$14.27 /

+0.4 (+2.88%)

04/02/19 Baird
China data, plastics trends positive indicators for Milacron, says Baird

TODAY'S FREE FLY STORIES

Earnings
Horizon Therapeutics raises FY20 revenue view to $1.85B-$1.9B from $1.4B-$1.45B » 07:26
08/05/20
08/05
07:26
08/05/20
07:26
HZNP

Horizon Therapeutics

$61.78 /

-1.3 (-2.06%)

Consensus $1.54B. Horizon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HZNP Horizon Therapeutics
$61.78 /

-1.3 (-2.06%)

HZNP Horizon Therapeutics
$61.78 /

-1.3 (-2.06%)

07/31/20 Stifel
Horizon Therapeutics price target raised to $85 from $60 at Stifel
07/31/20 Morgan Stanley
Horizon Therapeutics price target raised to $70 from $50 at Morgan Stanley
07/22/20 Piper Sandler
Horizon Therapeutics price target raised to $90 from $61 at Piper Sandler
07/16/20 Guggenheim
Horizon Therapeutics price target raised to $64 from $50 at Guggenheim
HZNP Horizon Therapeutics
$61.78 /

-1.3 (-2.06%)

Hot Stocks
Axsome Therapeutics receives Breakthrough Therapy designation for AXS-12 » 07:26
08/05/20
08/05
07:26
08/05/20
07:26
AXSM

Axsome Therapeutics

$74.73 /

-1.59 (-2.08%)

Axsome Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AXSM Axsome Therapeutics
$74.73 /

-1.59 (-2.08%)

AXSM Axsome Therapeutics
$74.73 /

-1.59 (-2.08%)

07/13/20 Oppenheimer
Relmada Therapeutics initiated with an Outperform at Oppenheimer
04/28/20 Guggenheim
Axsome Therapeutics price target raised to $200 from $158 at Guggenheim
04/28/20 SunTrust
Axsome Therapeutics price target raised to $200 from $145 at SunTrust
04/28/20 Cantor Fitzgerald
Axsome Therapeutics price target raised to $131 from $125 at Cantor Fitzgerald
AXSM Axsome Therapeutics
$74.73 /

-1.59 (-2.08%)

  • 19
    Dec
AXSM Axsome Therapeutics
$74.73 /

-1.59 (-2.08%)

AXSM Axsome Therapeutics
$74.73 /

-1.59 (-2.08%)

Earnings
Horizon Therapeutics reports Q2 EPS 40c, consensus 36c » 07:25
08/05/20
08/05
07:25
08/05/20
07:25
HZNP

Horizon Therapeutics

$61.78 /

-1.3 (-2.06%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HZNP Horizon Therapeutics
$61.78 /

-1.3 (-2.06%)

HZNP Horizon Therapeutics
$61.78 /

-1.3 (-2.06%)

07/31/20 Stifel
Horizon Therapeutics price target raised to $85 from $60 at Stifel
07/31/20 Morgan Stanley
Horizon Therapeutics price target raised to $70 from $50 at Morgan Stanley
07/22/20 Piper Sandler
Horizon Therapeutics price target raised to $90 from $61 at Piper Sandler
07/16/20 Guggenheim
Horizon Therapeutics price target raised to $64 from $50 at Guggenheim
HZNP Horizon Therapeutics
$61.78 /

-1.3 (-2.06%)

Conference/Events
UBS quantitative analyst to hold an analyst/industry conference call » 07:25
08/05/20
08/05
07:25
08/05/20
07:25

Global Head of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Hepion Pharmaceuticals announces first NASH patient dosed with CRV431 » 07:24
08/05/20
08/05
07:24
08/05/20
07:24
HEPA

Hepion Pharmaceuticals

$4.05 /

+0.02 (+0.50%)

Hepion Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HEPA Hepion Pharmaceuticals
$4.05 /

+0.02 (+0.50%)

HEPA Hepion Pharmaceuticals
$4.05 /

+0.02 (+0.50%)

07/20/20 Roth Capital
Hepion Pharmaceuticals transferred with a Buy rating at Roth Capital
03/20/20 Roth Capital
Roth Capital says Hepion's CRV431 could be used in COVID-19 treatment
11/22/19 Brookline
Hepion Pharmaceuticals initiated with a Buy at Brookline
11/07/19
Fly Intel: Top analyst initiations
HEPA Hepion Pharmaceuticals
$4.05 /

+0.02 (+0.50%)

Hot Stocks
Verrica enters option agreement with Torii Pharmaceutical for VP-102 » 07:24
08/05/20
08/05
07:24
08/05/20
07:24
VRCA

Verrica Pharmaceuticals

$6.43 /

-0.01 (-0.16%)

Verrica Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRCA Verrica Pharmaceuticals
$6.43 /

-0.01 (-0.16%)

VRCA Verrica Pharmaceuticals
$6.43 /

-0.01 (-0.16%)

07/15/20 BofA
Verrica Pharmaceuticals downgraded to Neutral from Buy at BofA
06/30/20 H.C. Wainwright
Verrica Pharmaceuticals price target lowered to $18 from $24 at H.C. Wainwright
06/24/20 Northland
Verrica Pharmaceuticals initiated with an Outperform at Northland
03/24/20
Fly Intel: Top five analyst initiations
VRCA Verrica Pharmaceuticals
$6.43 /

-0.01 (-0.16%)

VRCA Verrica Pharmaceuticals
$6.43 /

-0.01 (-0.16%)

Initiation
Inventiva initiated with a Buy at Roth Capital » 07:24
08/05/20
08/05
07:24
08/05/20
07:24
IVA

Inventiva

$10.76 /

+0.76 (+7.60%)

Roth Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IVA Inventiva
$10.76 /

+0.76 (+7.60%)

08/04/20
Fly Intel: Top five analyst initiations
08/04/20 Guggenheim
Guggenheim starts 'underappreciated' Inventiva at Buy with $26 price target
08/04/20 Stifel
Inventiva initiated with a Buy at Stifel
08/04/20 Guggenheim
Inventiva initiated with a Buy at Guggenheim
  • 10
    Jul
Earnings
Donnelley Financial Solutions reports Q2 EPS 87c, consensus 27c » 07:23
08/05/20
08/05
07:23
08/05/20
07:23
DFIN

Donnelley Financial Solutions

$9.87 /

+0.835 (+9.24%)

Reports Q2 revenue $254M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DFIN Donnelley Financial Solutions
$9.87 /

+0.835 (+9.24%)

DFIN Donnelley Financial Solutions
$9.87 /

+0.835 (+9.24%)

05/27/20 BTIG
Donnelley Financial Solutions initiated with a Buy at BTIG
10/22/19 DA Davidson
Donnelley Financial price target lowered to $21 from $25 at DA Davidson
10/16/19 B. Riley FBR
B. Riley FBR starts Donnelley Financial Solutions with Buy rating, $16 target
10/15/19 B. Riley FBR
Donnelley Financial Solutions initiated with a Buy at B. Riley FBR
DFIN Donnelley Financial Solutions
$9.87 /

+0.835 (+9.24%)

Hot Stocks
Sabre partners with ASKY » 07:23
08/05/20
08/05
07:23
08/05/20
07:23
SABR

Sabre

$7.96 /

+0.32 (+4.19%)

West-African airline,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SABR Sabre
$7.96 /

+0.32 (+4.19%)

SABR Sabre
$7.96 /

+0.32 (+4.19%)

05/11/20 Bernstein
Bernstein upgrades Sabre to Outperform ahead of air travel returning
05/11/20
Sabre upgraded to Outperform from Market Perform at Bernstein
04/13/20 Mizuho
Sabre price target raised to $5 from $3 at Mizuho
03/23/20 Mizuho
Sabre downgraded to Underperform from Buy at Mizuho
SABR Sabre
$7.96 /

+0.32 (+4.19%)

SABR Sabre
$7.96 /

+0.32 (+4.19%)

SABR Sabre
$7.96 /

+0.32 (+4.19%)

Hot Stocks
Evergy announces transformation plan following board's independent review  07:23
08/05/20
08/05
07:23
08/05/20
07:23
EVRG

Evergy

$55.45 /

-7.28 (-11.61%)

 
ShowHide Related Items >><<
EVRG Evergy
$55.45 /

-7.28 (-11.61%)

EVRG Evergy
$55.45 /

-7.28 (-11.61%)

08/03/20 Wolfe Research
Evergy downgraded to Peer Perform from Outperform at Wolfe Research
07/06/20 Wells Fargo
Evergy price target raised to $66 from $60 at Wells Fargo
06/03/20 Evercore ISI
Evergy upgraded to Outperform from In Line at Evercore ISI
03/03/20 BofA
Evergy upgraded to Buy from Underperform at BofA
EVRG Evergy
$55.45 /

-7.28 (-11.61%)

EVRG Evergy
$55.45 /

-7.28 (-11.61%)

Recommendations
LivePerson price target raised to $60 from $50 at Benchmark » 07:22
08/05/20
08/05
07:22
08/05/20
07:22
LPSN

LivePerson

$46.25 /

+0.95 (+2.10%)

Benchmark analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LPSN LivePerson
$46.25 /

+0.95 (+2.10%)

LPSN LivePerson
$46.25 /

+0.95 (+2.10%)

06:48 Today Mizuho
LivePerson price target raised to $65 from $45 at Mizuho
05:03 Today Jefferies
LivePerson price target raised to $55 from $33 at Jefferies
07/29/20 B. Riley FBR
LivePerson price target raised to $49 from $43 at B. Riley FBR
07/06/20 Benchmark
LivePerson price target raised to $50 from $43 at Benchmark
LPSN LivePerson
$46.25 /

+0.95 (+2.10%)

LPSN LivePerson
$46.25 /

+0.95 (+2.10%)

LPSN LivePerson
$46.25 /

+0.95 (+2.10%)

LPSN LivePerson
$46.25 /

+0.95 (+2.10%)

Hot Stocks
Evergy reveals transformation plan with 6%-8% EPS growth through 2024 » 07:22
08/05/20
08/05
07:22
08/05/20
07:22
EVRG

Evergy

$55.45 /

-7.28 (-11.61%)

Evergy announced its new…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EVRG Evergy
$55.45 /

-7.28 (-11.61%)

EVRG Evergy
$55.45 /

-7.28 (-11.61%)

08/03/20 Wolfe Research
Evergy downgraded to Peer Perform from Outperform at Wolfe Research
07/06/20 Wells Fargo
Evergy price target raised to $66 from $60 at Wells Fargo
06/03/20 Evercore ISI
Evergy upgraded to Outperform from In Line at Evercore ISI
03/03/20 BofA
Evergy upgraded to Buy from Underperform at BofA
EVRG Evergy
$55.45 /

-7.28 (-11.61%)

EVRG Evergy
$55.45 /

-7.28 (-11.61%)

Hot Stocks
GasLog CEO Andy Orekar to step down, Paul Wogan to succeed » 07:22
08/05/20
08/05
07:22
08/05/20
07:22
GLOG

GasLog

$3.16 /

+0.145 (+4.81%)

, GLOP

GasLog Partners

$3.94 /

+0.02 (+0.51%)

GasLog (GLOG) and GasLog…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GLOG GasLog
$3.16 /

+0.145 (+4.81%)

GLOP GasLog Partners
$3.94 /

+0.02 (+0.51%)

GLOG GasLog
$3.16 /

+0.145 (+4.81%)

06/23/20 Fearnley
GasLog downgraded to Hold from Buy at Fearnley
06/02/20 Pareto
GasLog downgraded to Sell from Hold at Pareto
03/31/20 Pareto
GasLog upgraded to Hold from Sell at Pareto
03/09/20 DNB Markets
GasLog downgraded to Hold from Buy at DNB Markets
GLOP GasLog Partners
$3.94 /

+0.02 (+0.51%)

04/30/20 BTIG
GasLog Partners cut to Neutral at BTIG on valuation
04/30/20 BTIG
GasLog Partners downgraded to Neutral from Buy at BTIG
02/07/20 Citi
GasLog Partners downgraded to Neutral from Buy at Citi
02/07/20 Citi
GasLog downgraded to Neutral from Buy at Citi
GLOG GasLog
$3.16 /

+0.145 (+4.81%)

GLOP GasLog Partners
$3.94 /

+0.02 (+0.51%)

GLOP GasLog Partners
$3.94 /

+0.02 (+0.51%)

GLOP GasLog Partners
$3.94 /

+0.02 (+0.51%)

Earnings
Sempra Energy backs FY20 adj. EPS view $7.20-$7.80, consensus $7.48  07:22
08/05/20
08/05
07:22
08/05/20
07:22
SRE

Sempra Energy

$125.04 /

+0.98 (+0.79%)

 
ShowHide Related Items >><<
SRE Sempra Energy
$125.04 /

+0.98 (+0.79%)

SRE Sempra Energy
$125.04 /

+0.98 (+0.79%)

07/21/20 KeyBanc
KeyBanc upgrades Sempra Energy to Overweight with $141 target
07/21/20 KeyBanc
KeyBanc downgrades DTE Energy, prefers Sempra for cyclical exposure
07/21/20 KeyBanc
Sempra Energy upgraded to Overweight from Sector Weight at KeyBanc
06/15/20 Seaport Global
Seaport Global starts Sempra Energy at Buy with $142 price target
SRE Sempra Energy
$125.04 /

+0.98 (+0.79%)

Earnings
Moderna reports Q2 EPS (31c), consensus (35c) » 07:21
08/05/20
08/05
07:21
08/05/20
07:21
MRNA

Moderna

$78.48 /

+0.5 (+0.64%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRNA Moderna
$78.48 /

+0.5 (+0.64%)

MRNA Moderna
$78.48 /

+0.5 (+0.64%)

08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/27/20 Piper Sandler
Piper reiterates $134 Moderna target on start of Phase III vaccine trial
07/27/20 BMO Capital
Moderna price target lowered to $94 from $112 at BMO Capital
MRNA Moderna
$78.48 /

+0.5 (+0.64%)

  • 19
    May
  • 12
    Feb
MRNA Moderna
$78.48 /

+0.5 (+0.64%)

MRNA Moderna
$78.48 /

+0.5 (+0.64%)

MRNA Moderna
$78.48 /

+0.5 (+0.64%)

Hot Stocks
Discovery reports Q2 adjusted OIBDA down 12% to $1.127B » 07:21
08/05/20
08/05
07:21
08/05/20
07:21
DISCA

Discovery

$22.00 /

+0.67 (+3.14%)

Q2 free cash flow was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DISCA Discovery
$22.00 /

+0.67 (+3.14%)

DISCA Discovery
$22.00 /

+0.67 (+3.14%)

07/13/20 Goldman Sachs
Discovery initiated with a Neutral at Goldman Sachs
06/30/20 Deutsche Bank
Discovery price target lowered to $30 from $38 at Deutsche Bank
06/29/20 Imperial Capital
Discovery price target lowered to $30 from $32 at Imperial Capital
05/14/20 Barrington
Discovery price target lowered to $28 from $34 at Barrington
DISCA Discovery
$22.00 /

+0.67 (+3.14%)

DISCA Discovery
$22.00 /

+0.67 (+3.14%)

DISCA Discovery
$22.00 /

+0.67 (+3.14%)

Earnings
CECO Environmental reports Q2 non-GAAP EPS 14c, consensus 8c » 07:21
08/05/20
08/05
07:21
08/05/20
07:21
CECE

CECO Environmental

$6.69 /

-0.195 (-2.83%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CECE CECO Environmental
$6.69 /

-0.195 (-2.83%)

CECE CECO Environmental
$6.69 /

-0.195 (-2.83%)

08/09/19
Fly Intel: Top five analyst initiations
08/09/19 Needham
CECO Environmental resumed with a Buy at Needham
CECE CECO Environmental
$6.69 /

-0.195 (-2.83%)

Earnings
Sempra Energy reports Q2 adj. EPS $1.65, consensus $1.50 » 07:20
08/05/20
08/05
07:20
08/05/20
07:20
SRE

Sempra Energy

$125.04 /

+0.98 (+0.79%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SRE Sempra Energy
$125.04 /

+0.98 (+0.79%)

SRE Sempra Energy
$125.04 /

+0.98 (+0.79%)

07/21/20 KeyBanc
KeyBanc upgrades Sempra Energy to Overweight with $141 target
07/21/20 KeyBanc
KeyBanc downgrades DTE Energy, prefers Sempra for cyclical exposure
07/21/20 KeyBanc
Sempra Energy upgraded to Overweight from Sector Weight at KeyBanc
06/15/20 Seaport Global
Seaport Global starts Sempra Energy at Buy with $142 price target
SRE Sempra Energy
$125.04 /

+0.98 (+0.79%)

Earnings
AmerisourceBergen raises FY20 adj. EPS view to $7.80-$7.95 from $7.35-$7.65 » 07:20
08/05/20
08/05
07:20
08/05/20
07:20
ABC

AmerisourceBergen

$104.86 /

+0.36 (+0.34%)

Consensus $7.45.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ABC AmerisourceBergen
$104.86 /

+0.36 (+0.34%)

ABC AmerisourceBergen
$104.86 /

+0.36 (+0.34%)

06/15/20 Morgan Stanley
Morgan Stanley upgrades AmerisourceBergen on opioid settlement potential
06/15/20 Morgan Stanley
AmerisourceBergen upgraded to Overweight from Equal Weight at Morgan Stanley
05/22/20 Wolfe Research
McKesson upgraded to Outperform from Peer Perform at Wolfe Research
05/18/20 Argus
Argus sees long term growth opportunities for AmerisourceBergen
ABC AmerisourceBergen
$104.86 /

+0.36 (+0.34%)

ABC AmerisourceBergen
$104.86 /

+0.36 (+0.34%)

ABC AmerisourceBergen
$104.86 /

+0.36 (+0.34%)

ABC AmerisourceBergen
$104.86 /

+0.36 (+0.34%)

Hot Stocks
Verrica Pharmaceuticals expects cash to support operations at least through 4Q21 » 07:19
08/05/20
08/05
07:19
08/05/20
07:19
VRCA

Verrica Pharmaceuticals

$6.43 /

-0.01 (-0.16%)

As of June 30, 2020,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRCA Verrica Pharmaceuticals
$6.43 /

-0.01 (-0.16%)

VRCA Verrica Pharmaceuticals
$6.43 /

-0.01 (-0.16%)

07/15/20 BofA
Verrica Pharmaceuticals downgraded to Neutral from Buy at BofA
06/30/20 H.C. Wainwright
Verrica Pharmaceuticals price target lowered to $18 from $24 at H.C. Wainwright
06/24/20 Northland
Verrica Pharmaceuticals initiated with an Outperform at Northland
03/24/20
Fly Intel: Top five analyst initiations
VRCA Verrica Pharmaceuticals
$6.43 /

-0.01 (-0.16%)

VRCA Verrica Pharmaceuticals
$6.43 /

-0.01 (-0.16%)

Earnings
Verrica Pharmaceuticals reports Q2 EPS (38c), consensus (45c) » 07:19
08/05/20
08/05
07:19
08/05/20
07:19
VRCA

Verrica Pharmaceuticals

$6.43 /

-0.01 (-0.16%)

"We have made recent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRCA Verrica Pharmaceuticals
$6.43 /

-0.01 (-0.16%)

VRCA Verrica Pharmaceuticals
$6.43 /

-0.01 (-0.16%)

07/15/20 BofA
Verrica Pharmaceuticals downgraded to Neutral from Buy at BofA
06/30/20 H.C. Wainwright
Verrica Pharmaceuticals price target lowered to $18 from $24 at H.C. Wainwright
06/24/20 Northland
Verrica Pharmaceuticals initiated with an Outperform at Northland
03/24/20
Fly Intel: Top five analyst initiations
VRCA Verrica Pharmaceuticals
$6.43 /

-0.01 (-0.16%)

VRCA Verrica Pharmaceuticals
$6.43 /

-0.01 (-0.16%)

Recommendations
2021 could be 'big year' for Apple iPhones, says Bernstein » 07:19
08/05/20
08/05
07:19
08/05/20
07:19
AAPL

Apple

$438.80 /

+3.14 (+0.72%)

Bernstein analyst Toni…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AAPL Apple
$438.80 /

+3.14 (+0.72%)

AAPL Apple
$438.80 /

+3.14 (+0.72%)

06:19 Today BofA
BofA downgrades Apple to Neutral, ups price target to $470
06:09 Today BofA
Apple downgraded to Neutral from Buy at BofA
08/04/20 Susquehanna
Cirrus Logic price target raised to $86 from $78 at Susquehanna
07/31/20 Canaccord
Canaccord boosts Apple target to $460 after 'impressive' quarter
AAPL Apple
$438.80 /

+3.14 (+0.72%)

AAPL Apple
$438.80 /

+3.14 (+0.72%)

AAPL Apple
$438.80 /

+3.14 (+0.72%)

AAPL Apple
$438.80 /

+3.14 (+0.72%)

AAPL Apple
$438.80 /

+3.14 (+0.72%)

Earnings
Ionis Pharmaceuticals reports Q2 EPS (23c), consensus (27c) » 07:19
08/05/20
08/05
07:19
08/05/20
07:19
IONS

Ionis Pharmaceuticals

$59.25 /

+0.02 (+0.03%)

Reports Q2 revenue $146M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IONS Ionis Pharmaceuticals
$59.25 /

+0.02 (+0.03%)

IONS Ionis Pharmaceuticals
$59.25 /

+0.02 (+0.03%)

07/20/20 BMO Capital
Alnylam price target raised to $196 from $173 at BMO Capital
06/05/20 Citi
Ionis Pharmaceuticals price target raised to $80 from $71 at Citi
05/12/20 RBC Capital
Ionis Pharmaceuticals initiated with an Outperform at RBC Capital
04/22/20 Jefferies
Jefferies remains cautious on Ionis after report from partner Biogen
IONS Ionis Pharmaceuticals
$59.25 /

+0.02 (+0.03%)

IONS Ionis Pharmaceuticals
$59.25 /

+0.02 (+0.03%)

Earnings
Evergy sees FY20 adjusted EPS $2.90-$3.10, consensus $3.05  07:19
08/05/20
08/05
07:19
08/05/20
07:19
EVRG

Evergy

$55.45 /

-7.28 (-11.61%)

 
ShowHide Related Items >><<
EVRG Evergy
$55.45 /

-7.28 (-11.61%)

EVRG Evergy
$55.45 /

-7.28 (-11.61%)

08/03/20 Wolfe Research
Evergy downgraded to Peer Perform from Outperform at Wolfe Research
07/06/20 Wells Fargo
Evergy price target raised to $66 from $60 at Wells Fargo
06/03/20 Evercore ISI
Evergy upgraded to Outperform from In Line at Evercore ISI
03/03/20 BofA
Evergy upgraded to Buy from Underperform at BofA
EVRG Evergy
$55.45 /

-7.28 (-11.61%)

EVRG Evergy
$55.45 /

-7.28 (-11.61%)

Hot Stocks
Teva, Alvotech announce partnership to commercialize five biosimilar candidates » 07:18
08/05/20
08/05
07:18
08/05/20
07:18
TEVA

Teva

$11.80 /

-0.385 (-3.16%)

Teva and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TEVA Teva
$11.80 /

-0.385 (-3.16%)

TEVA Teva
$11.80 /

-0.385 (-3.16%)

07/27/20 Goldman Sachs
Teva initiated with a Neutral at Goldman Sachs
07/02/20 Wells Fargo
Emergent BioSolutions price target raised to $93 from $85 at Wells Fargo
06/26/20 William Blair
Pfenex partner CHMP opinion 'material de-risking event,' says William Blair
06/17/20 Stifel
Amarin settlement with Apotex an 'incremental positive,' says Stifel
TEVA Teva
$11.80 /

-0.385 (-3.16%)

TEVA Teva
$11.80 /

-0.385 (-3.16%)

TEVA Teva
$11.80 /

-0.385 (-3.16%)

TEVA Teva
$11.80 /

-0.385 (-3.16%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.